User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.

Primary tabs

download
  • Open access
  • PDF
  • 502.60 K
Viollet, Benoit Foretz, Marc Guigas, Bruno [UCL] Horman, Sandrine [UCL] Dentin, Renaud Bertrand, Luc [UCL] Hue, Louis [UCL] Andreelli, Fabrizio

It is now becoming evident that the liver has an important role in the control of whole body metabolism of energy nutrients. In this review, we focus on recent findings showing that AMP-activated protein kinase (AMPK) plays a major role in the control of hepatic metabolism. AMPK integrates nutritional and hormonal signals to promote energy balance by switching on catabolic pathways and switching off ATP-consuming pathways, both by short-term effects on phosphorylation of regulatory proteins and by long-term effects on gene expression. Activation of AMPK in the liver leads to the stimulation of fatty acid oxidation and inhibition of lipogenesis, glucose production and protein synthesis. Medical interest in the AMPK system has recently increased with the demonstration that AMPK could mediate some of the effects of the fat cell-derived adiponectin and the antidiabetic drugs metformin and thiazolidinediones. These findings reinforce the idea that pharmacological activation of AMPK may provide, through signalling and metabolic and gene expression effects, a new strategy for the management of metabolic hepatic disorders linked to type 2 diabetes and obesity.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2006
Journal information "The Journal of physiology" - Vol. 574, no. Pt 1, p. 41-53 (2006)
Peer reviewed yes
issn 0022-3751
Publication status Publié
Affiliation UCL - MD/BICL - Département de biochimie et de biologie cellulaire
MESH Subject AMP-Activated Protein Kinases ; Animals ; Diabetes Mellitus, Type 2 - drug therapy - enzymology ; Enzyme Activation - drug effects ; Glucose - metabolism ; Glycogen - metabolism ; Humans ; Liver - drug effects - enzymology ; Liver Diseases - drug therapy - enzymology ; Multienzyme Complexes - drug effects - metabolism ; Obesity - drug therapy - enzymology ; Protein-Serine-Threonine Kinases - drug effects - metabolism
Links
  1. Abu-Elheiga L., Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2, 10.1126/science.1056843
  2. Andreelli Fabrizio, Foretz Marc, Knauf Claude, Cani Patrice D., Perrin Christophe, Iglesias Miguel A., Pillot Bruno, Bado André, Tronche François, Mithieux Gilles, Vaulont Sophie, Burcelin Rémy, Viollet Benoit, Liver Adenosine Monophosphate-Activated Kinase-α2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not Insulin, 10.1210/en.2005-0898
  3. Assifi M. M., AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats, 10.1152/ajpendo.00144.2005
  4. Bajaj M., Suraamornkul S., Pratipanawatr T., Hardies L. J., Pratipanawatr W., Glass L., Cersosimo E., Miyazaki Y., DeFronzo R. A., Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes, 10.2337/diabetes.52.6.1364
  5. Barthel Andreas, Schmoll Dieter, Krüger Klaus-Dieter, Roth Richard A., Joost Hans-Georg, Regulation of the Forkhead Transcription Factor FKHR (FOXO1a) by Glucose Starvation and AICAR, an Activator of AMP-Activated Protein Kinase, 10.1210/endo.143.8.8792
  6. Berg Anders H., Combs Terry P., Du Xueliang, Brownlee Michael, Scherer Philipp E., 10.1038/90992
  7. Bergeron R., Previs S. F., Cline G. W., Perret P., Russell III R. R., Young L. H., Shulman G. I., Effect of 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside Infusion on In Vivo Glucose and Lipid Metabolism in Lean and Obese Zucker Rats, 10.2337/diabetes.50.5.1076
  8. Birnbaum Morris J., Activating AMP-Activated Protein Kinase without AMP, 10.1016/j.molcel.2005.07.012
  9. Browne Gareth J., Finn Stephen G., Proud Christopher G., Stimulation of the AMP-activated Protein Kinase Leads to Activation of Eukaryotic Elongation Factor 2 Kinase and to Its Phosphorylation at a Novel Site, Serine 398, 10.1074/jbc.m309773200
  10. Cheng Susan W. Y., Fryer Lee G. D., Carling David, Shepherd Peter R., Thr2446Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status, 10.1074/jbc.c300534200
  11. CHEUNG Peter C. F., SALT Ian P., DAVIES Stephen P., HARDIE D. Grahame, CARLING David, Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding, 10.1042/bj3460659
  12. Clarke, EMBO J, 9, 2439 (1990)
  13. Corton Julia M., Gillespie John G., Hawley Simon A., Hardie D. Grahame, 5-Aminoimidazole-4-Carboxamide Ribonucleoside. A Specific Method for Activating AMP-Activated Protein Kinase in Intact Cells?, 10.1111/j.1432-1033.1995.tb20498.x
  14. Dentin R., Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation, 10.1172/jci25256
  15. Evans J. M M, Metformin and reduced risk of cancer in diabetic patients, 10.1136/bmj.38415.708634.f7
  16. Ferré P., Azzout-Marniche D., Foufelle F., AMP-activated protein kinase and hepatic genes involved in glucose metabolism, 10.1042/bst0310220
  17. Foretz M., Ancellin N., Andreelli F., Saintillan Y., Grondin P., Kahn A., Thorens B., Vaulont S., Viollet B., Short-Term Overexpression of a Constitutively Active Form of AMP-Activated Protein Kinase in the Liver Leads to Mild Hypoglycemia and Fatty Liver, 10.2337/diabetes.54.5.1331
  18. Guigas B., Bertrand L., Taleux N., Foretz M., Wiernsperger N., Vertommen D., Andreelli F., Viollet B., Hue L., 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase-Independent Effect on Glucokinase Translocation, 10.2337/diabetes.55.04.06.db05-1178
  19. Hardie D. G., The AMP-activated protein kinase pathway - new players upstream and downstream, 10.1242/jcs.01540
  20. Hong Yu Holly, Varanasi Usha S., Yang Wenbo, Leff Todd, AMP-activated Protein Kinase Regulates HNF4α Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability, 10.1074/jbc.m304112200
  21. Horman Sandrine, Browne Gareth J., Krause Ulrike, Patel Jigna V., Vertommen Didier, Bertrand Luc, Lavoinne Alain, Hue Louis, Proud Christopher G., Rider Mark H., Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis, 10.1016/s0960-9822(02)01077-1
  22. Inoki Ken, Zhu Tianqing, Guan Kun-Liang, TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival, 10.1016/s0092-8674(03)00929-2
  23. Kawaguchi Takumi, Osatomi Kiyoshi, Yamashita Hiromi, Kabashima Tsutomu, Uyeda Kosaku, Mechanism for Fatty Acid “Sparing” Effect on Glucose-induced Transcription : REGULATION OF CARBOHYDRATE-RESPONSIVE ELEMENT-BINDING PROTEIN BY AMP-ACTIVATED PROTEIN KINASE, 10.1074/jbc.m107895200
  24. Kodama S., Koike C., Negishi M., Yamamoto Y., Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes, 10.1128/mcb.24.18.7931-7940.2004
  25. Koo Seung-Hoi, Flechner Lawrence, Qi Ling, Zhang Xinmin, Screaton Robert A., Jeffries Shawn, Hedrick Susan, Xu Wu, Boussouar Fayçal, Brindle Paul, Takemori Hiroshi, Montminy Marc, The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism, 10.1038/nature03967
  26. Krause Ulrike, Bertrand Luc, Hue Louis, Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes : Inhibition of p70S6K activation by AMPK, 10.1046/j.1432-1033.2002.03074.x
  27. Krause Ulrike, Bertrand Luc, Maisin Liliane, Rosa Maria, Hue Louis, Signalling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes : Insulin and amino acid signalling in hepatocytes, 10.1046/j.1432-1033.2002.03069.x
  28. Leclerc I., Lenzner C., Gourdon L., Vaulont S., Kahn A., Viollet B., Hepatocyte Nuclear Factor-4  Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase, 10.2337/diabetes.50.7.1515
  29. Diehl Anna Mae, Lin Hui Zhi, Yang Shi Qi, Chuckaree Christine, Kuhajda Francis, Ronnet Gabriele, 10.1038/79697
  30. Liu Liping, Cash Timothy P., Jones Russell G., Keith Brian, Thompson Craig B., Simon M. Celeste, Hypoxia-Induced Energy Stress Regulates mRNA Translation and Cell Growth, 10.1016/j.molcel.2006.01.010
  31. Lizcano Jose M, Göransson Olga, Toth Rachel, Deak Maria, Morrice Nick A, Boudeau Jérôme, Hawley Simon A, Udd Lina, Mäkelä Tomi P, Hardie D Grahame, Alessi Dario R, LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1, 10.1038/sj.emboj.7600110
  32. Luo Zhijun, Saha Asish K., Xiang Xiaoqin, Ruderman Neil B., AMPK, the metabolic syndrome and cancer, 10.1016/j.tips.2004.12.011
  33. MUNDAY Michael R., CAMPBELL David G., CARLING David, HARDIE D. Grahame, Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase, 10.1111/j.1432-1033.1988.tb14201.x
  34. MUOIO Deborah M., SEEFELD Kimberly, WITTERS Lee A., COLEMAN Rosalind A., AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target, 10.1042/bj3380783
  35. Nawrocki Andrea R., Rajala Michael W., Tomas Eva, Pajvani Utpal B., Saha Asish K., Trumbauer Myrna E., Pang Zhen, Chen Airu S., Ruderman Neil B., Chen Howard, Rossetti Luciano, Scherer Philipp E., Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists, 10.1074/jbc.m505311200
  36. Pencek R. R., Shearer J., Camacho R. C., James F. D., Lacy D. B., Fueger P. T., Donahue E. P., Snead W., Wasserman D. H., 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo, 10.2337/diabetes.54.2.355
  37. Peralta, Am J Physiol Gastrointest Liver Physiol, 279, G163 (2000)
  38. Peralta C, Adenosine monophosphate[ndash ]activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat, 10.1053/jhep.2001.29197
  39. Proud, Curr Top Microbiol Immunol, 279, 215 (2004)
  40. Rao Ravi, Buckner Jan, Sarkaria Jann, Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents, 10.2174/1568009043332718
  41. Reiter A. K., Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside, 10.1152/ajpendo.00333.2004
  42. Rencurel Franck, Stenhouse Alasdair, Hawley Simon A., Friedberg Thomas, Hardie D. Grahame, Sutherland Calum, Wolf C. Roland, AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line, 10.1074/jbc.m412711200
  43. Saha Asish K, Avilucea Paco R, Ye Ji-Ming, Assifi Murwarid M, Kraegen Edward W, Ruderman Neil B, Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo, 10.1016/j.bbrc.2003.12.120
  44. SALT Ian, CELLER Jakub W., HAWLEY Simon A., PRESCOTT Alan, WOODS Angela, CARLING David, HARDIE D. Grahame, AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform, 10.1042/bj3340177
  45. Sarbassov Dos D, Ali Siraj M, Sabatini David M, Growing roles for the mTOR pathway, 10.1016/j.ceb.2005.09.009
  46. Satoh Hiroaki, Nguyen M.T. Audrey, Miles Philip D.G., Imamura Takeshi, Usui Isao, Olefsky Jerrold M., Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats, 10.1172/jci20785
  47. Screaton Robert A., Conkright Michael D., Katoh Yoshiko, Best Jennifer L., Canettieri Gianluca, Jeffries Shawn, Guzman Ernesto, Niessen Sherry, Yates John R., Takemori Hiroshi, Okamoto Mitsuhiro, Montminy Marc, The CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector, 10.1016/j.cell.2004.09.015
  48. Shaw R. J., The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin, 10.1126/science.1120781
  49. Viollet Benoit, Andreelli Fabrizio, Jørgensen Sebastian B., Perrin Christophe, Geloen Alain, Flamez Daisy, Mu James, Lenzner Claudia, Baud Olivier, Bennoun Myriam, Gomas Emmanuel, Nicolas Gaël, Wojtaszewski Jørgen F.P., Kahn Axel, Carling David, Schuit Frans C., Birnbaum Morris J., Richter Erik A., Burcelin Rémy, Vaulont Sophie, The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity, 10.1172/jci16567
  50. Winder, J Appl Physiol, 82, 219 (1997)
  51. Witters, J Biol Chem, 267, 2864 (1992)
  52. Xu Aimin, Wang Yu, Keshaw Hussila, Xu Lance Yi, Lam Karen S.L., Cooper Garth J.S., The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice, 10.1172/jci200317797
  53. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, 10.1038/nm788
  54. You Min, Matsumoto Michinaga, Pacold Christine M., Cho Won Kyoo, Crabb David W., The role of AMP-activated protein kinase in the action of ethanol in the liver, 10.1053/j.gastro.2004.09.049
  55. Zhou Gaochao, Myers Robert, Li Ying, Chen Yuli, Shen Xiaolan, Fenyk-Melody Judy, Wu Margaret, Ventre John, Doebber Thomas, Fujii Nobuharu, Musi Nicolas, Hirshman Michael F., Goodyear Laurie J., Moller David E., Role of AMP-activated protein kinase in mechanism of metformin action, 10.1172/jci13505
Bibliographic reference Viollet, Benoit ; Foretz, Marc ; Guigas, Bruno ; Horman, Sandrine ; Dentin, Renaud ; et. al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.. In: The Journal of physiology, Vol. 574, no. Pt 1, p. 41-53 (2006)
Permanent URL http://hdl.handle.net/2078.1/25892